Belevue Heathcae
Investments
Interim Report as at 30.06.2025
Table of contents
Business Report 3-13
Performance/Multi-year comparison 3
Shareholder letter 7
Portfolio at a glance 13
Financial Report 14-25
Consolidated interim financial statements 14
Selected explanatory notes to the consolidated interim financial statements 18
Report of the statutory auditors 25
About us 26-36
Company profile 26
Investment strategy 27
Investment process 29
Board of Directors 31
Investment Manager 31
Shareholder information 32
Facts & figures 33
Corporate calendar 34
Contact 35
Performance/Multi-year comparison
Indexed performance since launch
BB Biotech AG (SIX)-CHF0
Rolling performance | Annual performance | |||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | |||
30.06.2024 - 30.06.2025 | (20.4%) | (18.7%) | (17.1%) | 2024 | (13.5%) | 3.0% | 7.6% | |
30.06.2023 - 30.06.2024 | 7.2% | 10.2% | 12.9% | 2023 | (18.1%) | (7.4%) | (4.8%) | |
30.06.2022 - 30.06.2023 | (27.1%) | (3.5%) | 2.8% | 2022 | (24.3%) | (11.0%) | (9.1%) | |
30.06.2021 - 30.06.2022 | (31.2%) | (32.4%) | (24.3%) | 2021 | 8.3% | (11.5%) | 3.0% | |
30.06.2020 - 30.06.2021 | 30.9% | 17.0% | 17.8% | 2020 | 19.3% | 24.3% | 15.8% | |
Cumulated performance
30.06.2025
Annualized performance
30.06.2025
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | |||
YTD | (9.8%) | (15.3%) | (13.8%) | 1 year | (20.4%) | (18.7%) | (17.1%) | |
1 year | (20.4%) | (18.7%) | (17.1%) | 3 years | (14.6%) | (4.8%) | (1.3%) | |
3 years | (37.8%) | (13.6%) | (3.8%) | 5 years | (10.9%) | (7.3%) | (3.0%) | |
5 years | (43.9%) | (31.6%) | (14.2%) | 10 years | (0.9%) | (2.0%) | (0.1%) | |
10 years | (8.8%) | (18.0%) | (1.0%) | since inception 1) | 9.0% | 9.4% | 8.2% | |
since inception 1) | 1 444% | 1 609% | 1 101% |
109.11.1993
109.11.1993
BB BIOTECH AG (XETRA)-EUR0
Rolling performance | Annual performance | |||||||
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | |||
30.06.2024 - 30.06.2025 | (18.6%) | (16.3%) | (14.6%) | 2024 | (14.1%) | 1.7% | 6.3% | |
30.06.2023 - 30.06.2024 | 8.6% | 11.9% | 14.5% | 2023 | (15.2%) | (1.3%) | 1.3% | |
30.06.2022 - 30.06.2023 | (25.9%) | (1.2%) | 5.2% | 2022 | (19.0%) | (6.7%) | (4.5%) | |
30.06.2021 - 30.06.2022 | (23.9%) | (25.9%) | (17.0%) | 2021 | 13.3% | (7.8%) | 7.4% | |
30.06.2020 - 30.06.2021 | 26.5% | 13.5% | 14.4% | 2020 | 18.1% | 24.8% | 16.1% | |
Cumulated performance
30.06.2025
Annualized performance
30.06.2025
SHARE | NAV | NBI TR | SHARE | NAV | NBI TR | |||
YTD | (9.6%) | (14.8%) | (13.3%) | 1 year | (18.6%) | (16.3%) | (14.6%) | |
1 year | (18.6%) | (16.3%) | (14.6%) | 3 years | (13.1%) | (2.6%) | 1.0% | |
3 years | (34.5%) | (7.5%) | 3.0% | 5 years | (8.8%) | (4.9%) | (0.5%) | |
5 years | (36.9%) | (22.2%) | (2.2%) | 10 years | 0.1% | (0.9%) | 1.0% | |
10 years | 0.8% | (8.7%) | 10.5% | since inception 1) | 10.1% | 10.5% | 9.9% | |
since inception 1) | 1 317% | 1 487% | 1 252% |
110.12.1997
110.12.1997